Fundamental Research (Jul 2023)

Artificial intelligence reinforced upconversion nanoparticle-based lateral flow assay via transfer learning

  • Wei Wang,
  • Kuo Chen,
  • Xing Ma,
  • Jinhong Guo

Journal volume & issue
Vol. 3, no. 4
pp. 544 – 556

Abstract

Read online

The combination of upconverting nanoparticles (UCNPs) and immunochromatography has become a widely used and promising new detection technique for point-of-care testing (POCT). However, their low luminescence efficiency, non-specific adsorption, and image noise have always limited their progress toward practical applications. Recently, artificial intelligence (AI) has demonstrated powerful representational learning and generalization capabilities in computer vision. We report for the first time a combination of AI and upconversion nanoparticle-based lateral flow assays (UCNP-LFAs) for the quantitative detection of commercial internet of things (IoT) devices. This universal UCNPs quantitative detection strategy combines high accuracy, sensitivity, and applicability in the field detection environment. By using transfer learning to train AI models in a small self-built database, we not only significantly improved the accuracy and robustness of quantitative detection, but also efficiently solved the actual problems of data scarcity and low computing power of POCT equipment. Then, the trained AI model was deployed in IoT devices, whereby the detection process does not require detailed data preprocessing to achieve real-time inference of quantitative results. We validated the quantitative detection of two detectors using eight transfer learning models on a small dataset. The AI quickly provided ultra-high accuracy prediction results (some models could reach 100% accuracy) even when strong noise was added. Simultaneously, the high flexibility of this strategy promises to be a general quantitative detection method for optical biosensors. We believe that this strategy and device have a scientific significance in revolutionizing the existing POCT technology landscape and providing excellent commercial value in the in vitro diagnostics (IVD) industry.

Keywords